Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.69
+0.55 (2.38%)
At close: Mar 9, 2026, 4:00 PM EDT
23.23
-0.46 (-1.94%)
After-hours: Mar 9, 2026, 6:44 PM EDT
AAPG Market Cap
AAPG has a market cap or net worth of $2.05 billion as of March 9, 2026. Its market cap has increased by 31.69% in one year.
Market Cap
2.05B
Enterprise Value
2.06B
1-Year Change
31.69%
Ranking
Category
Stock Price
$23.69
Market Cap Chart
Since the IPO on June 13, 2022, AAPG's market cap has increased from $554.36M to $2.05B, an increase of 270.17%. That is a compound annual growth rate of 41.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 2.05B | -16.96% |
| Dec 31, 2025 | 2.47B | 36.38% |
| Dec 31, 2024 | 1.81B | 82.20% |
| Dec 29, 2023 | 994.30M | 16.90% |
| Dec 30, 2022 | 850.58M | 53.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 2.24B |
| Day One Biopharmaceuticals | 2.19B |
| Zai Lab | 2.19B |
| Maze Therapeutics | 2.16B |
| Galapagos NV | 2.15B |
| Iovance Biotherapeutics | 2.11B |
| Mineralys Therapeutics | 2.10B |
| Mesoblast | 2.08B |